B
80/100
TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
HR or Marketing? Claim Your Free Employer Account
TG Therapeutics Team Employee Reviews
All
Positive
Constructive
What are some of the best things about your team?
Everyone is friendly and hardworking
What do your coworkers need to improve and how could you work together better?
Working together is better then working against one another.
It’s about working together, not a cut throat environme
×